Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromesMaciej Juryńczyk, Jacqueline Palace, de Sèze et al.|Journal of Neurology|2015Cited by 65
Abstract CT028: First-in-human phase I study of the nucleotide analogue NUC-3373 designed to overcome fluoropyrimidine drug resistance mechanismsSarah P. Blagden, Essam Ghazaly, Michaela Serpi et al.|Cancer Research|2016Cited by 5